Cytokines in the control of beta-2 microglobulin release. II. In vivo studies with recombinant interferons and antigens.

Abstract

The influence of in vivo application of recombinant interferon-alpha 2c (IFN-alpha 2c) and recombinant interferon-gamma (IFN-gamma) on beta-2 microglobulin levels was studied in eight patients with chronic myelogenous leukaemia or advanced renal cell carcinoma. Data indicated enhanced beta-2 microglobulin biosynthesis in close temporary association with injection of both types of interferons. The influence of in vivo stimulation by allogenic leukocytes and the influence of renal allografts or cytomegalovirus infection on serum beta-2 microglobulin and IFN-gamma levels were also studied. Increased beta-2 microglobulin concentrations were observed again in each of these clinical situations and were closely associated with enhanced endogenous interferon production. From these in vivo data and the in vitro data presented in the preceding publication, (1) we conclude that endogenous interferon levels are crucial for the regulation of beta-2 microglobulin release in vivo.

• Authors: K Nachbaur, J Troppmair, B Kotlan, P König, W Aulitzky, P Bieling, C Huber
• Journal: Immunobiology (Immunobiology) Vol. 177 Issue 1 Pg. 66-75 (Apr 1988) ISSN: 0171-2985 [Print] Netherlands
• PMID: 2454879 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Antigens
• Biological Products
• Cytokines
• Isoantibodies
• Recombinant Proteins
• beta 2-Microglobulin
• Interferon-gamma
• Interferons

Topics

• Antigens (pharmacology)
• Biological Products (pharmacology)
• Cytokines
• Cytomegalovirus Infections (blood, etiology)
• Graft Rejection
• Humans
• Interferon-gamma (metabolism)
• Interferons (pharmacokinetics, pharmacology)
• Isoantibodies (immunology)
• Kidney (physiology)
• Kidney Transplantation
• Recombinant Proteins (pharmacology)
• Transplantation, Homologous (adverse effects)
• beta 2-Microglobulin (metabolism)